December 15th, 2015

Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – [video] Biogen Has Many `Exciting’ Drugs in Pipeline: CEO

[at Bloomberg] – Jan. 14 (Bloomberg) — George Scangos, chief executive officer Biogen Idec Inc., talks about the company’s multiple sclerosis drugs, pipeline and outlook. Scangos speaks with Erik Schatzker and Stephanie . . . → Read More: Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – [video] Biogen Has Many `Exciting’ Drugs in Pipeline: CEO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.